183 related articles for article (PubMed ID: 1800378)
1. In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers.
Wiedemann B; Luhmer E; Zühlsdorf MT
Infection; 1991; 19(5):363-9. PubMed ID: 1800378
[TBL] [Abstract][Full Text] [Related]
2. Microbiological evaluation of cefpodoxime proxetil.
Wiedemann B; Luhmer E; Zühlsdorf MT
Drugs; 1991; 42 Suppl 3():6-12. PubMed ID: 1726210
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY 3522, cefuroxime, cefaclor and cefadroxil.
Bauernfeind A; Jungwirth R
Infection; 1991; 19(5):353-62. PubMed ID: 1800377
[TBL] [Abstract][Full Text] [Related]
4. Cefpodoxime: comparative antibacterial activity, influence of growth conditions, and bactericidal activity.
Knothe H; Shah PM; Eckardt O
Infection; 1991; 19(5):370-6. PubMed ID: 1800379
[TBL] [Abstract][Full Text] [Related]
5. [RU 51807 (cefpodoxime proxetil). In vitro and in vivo antibacterial activity of a new orally administered active cephalosporin].
Chantot JF; Mauvais P
Pathol Biol (Paris); 1991 Jan; 39(1):17-27. PubMed ID: 1901403
[TBL] [Abstract][Full Text] [Related]
6. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
Wise R; Andrews JM; Ashby JP; Thornber D
J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Sader HS; Jones RN; Washington JA; Murray PR; Gerlach EH; Allen SD; Erwin ME
Diagn Microbiol Infect Dis; 1993; 17(2):143-50. PubMed ID: 8243035
[TBL] [Abstract][Full Text] [Related]
8. Cefpodoxime: comparable evaluation with other orally available cephalosporins. With a note on the role of beta-lactamases.
Cullmann W; Dick W
Zentralbl Bakteriol; 1990 Sep; 273(4):501-17. PubMed ID: 2248685
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity and cross resistance studies with cefpodoxime.
Grimm H
Zentralbl Bakteriol; 1991 Dec; 276(1):54-62. PubMed ID: 1789901
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone.
Knapp CC; Sierra-Madero J; Washington JA
Antimicrob Agents Chemother; 1988 Dec; 32(12):1896-8. PubMed ID: 3245701
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activities of FK037: a new parenteral cephalosporin.
Inoue K; Inoue E; Mitsuhashi S
Chemotherapy; 1995; 41(4):257-66. PubMed ID: 7555206
[TBL] [Abstract][Full Text] [Related]
12. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
Dubreuil L; Derriennic M; Sedallian A
Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of pharmacokinetics/pharmacodynamics of cefdinir, cefpodoxime proxetil and cefaclor against common bacteria of community acquired infections].
Xiao YH; Gao L; Li Y; Lü Y; Liu J; Liu Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(22):1867-71. PubMed ID: 15631795
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity of cefpodoxime in vitro.
Liu YC; Huang WK; Cheng DL
Chemotherapy; 1997; 43(1):21-6. PubMed ID: 8996737
[TBL] [Abstract][Full Text] [Related]
15. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
16. Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Gerlach EH; Jones RN; Allen SD; Koontz FP; Murray PR; Pfaller MA; Washington JA; Erwin ME
Diagn Microbiol Infect Dis; 1992 Aug; 15(6):537-43. PubMed ID: 1424507
[TBL] [Abstract][Full Text] [Related]
17. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimicrobial spectrum and activity of ceftibuten against clinical isolates from West Germany.
Bauernfeind A
Diagn Microbiol Infect Dis; 1991; 14(1):63-74. PubMed ID: 2013211
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
Westblom TU; Gudipati S; Midkiff BR
Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):691-3. PubMed ID: 2226500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]